Background Spasticity is present in more than 80% of the population with cerebral palsy
(CP). The aim of this study was to describe and compare the use of three spasticity reducing …

Objective: To describe the current state of the art in the therapeutic administration of
botulinum toxin with indications, efficacy, and safety profile for children and adolescents with …

This study evaluated the effect of action observation training on spasticity, gross motor
function, and balance in children with spastic diplegia cerebral palsy. Eighteen children with …

(1) Background: Our study explores the relationship between expected, perceived, and
measured effects of botulinum toxin A (BoNT-A) treatment and saline (placebo) in children …

The impact of longitudinal surveillance of individuals with cerebral palsy in Norway; a 20-year
quality registry and follow-up Page 1 Norsk Epidemiologi 2023; 31 (1-2): 15-23. DOI …

Abstract Background The Swedish Healthcare Act states that patients should have equal
access to healthcare. This study addresses at how this translates to pharmacological …

Aim To compare the risks of adverse events 3 months after Onabotulinumtoxin‐A and
Lanbotulinumtoxin‐A injections in children with cerebral palsy (CP) and to identify risk …

From a periodontal point of view, various factors contribute to facial aesthetics. In the recent
past, studies have revealed that excessive gingival display is a factor that influences an …

Cerebral palsy (CP) is the most common cause of movement disorders in children and may
result in diverse levels of severity of the disability, from very mild to very severe. The …

La parálisis cerebral puede definirse como un término amplio que cubre un grupo de
síndromes de deterioro motor no progresivos, pero a menudo cambiantes, secundarios a …